U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 8

2.
Figure 2

Figure 2. From: Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells.

Chemical structures of isolated natural products 1 and 2 and similar diaryloxazoles reported from other plant species.

Andrew J. Robles, et al. J Med Chem. ;60(22):9275-9289.
3.
Figure 3

Figure 3. From: Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells.

Compound 17 more potently inhibits growth of MDA-MB-453 cells than natural product hits. SRB assay concentration-response curves for 17 (A) and potency measurements (B) in five TNBC cell lines representing different molecular subtypes. Results represent mean ± SE.

Andrew J. Robles, et al. J Med Chem. ;60(22):9275-9289.
4.
Figure 5

Figure 5. From: Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells.

Compound 30 rapidly decreases abundance of activated mTORC1 signaling proteins in LAR cells. Immunoblotting of compound 30-treated MDA-MB-453 whole-cell lysates for phosphorylated and total PI3K/Akt/mTORC1 signaling proteins. Cells were treated with vehicle (DMSO) or 1 μM 30 for 1 – 6 h, as indicated. Quantification of phosphorylated protein relative to total protein is indicated below each band.

Andrew J. Robles, et al. J Med Chem. ;60(22):9275-9289.
5.
Figure 1

Figure 1. From: Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells.

Amyris texana, extract and isolated compounds selectively inhibit growth of LAR cells. SRB assay concentration-response curves for a crude supercritical CO2 extract of Amyris texana (A); fractions F2 (B) and F3 (C); and isolated pure compounds 1 (D) and 2 (E) against TNBC cell lines representing different molecular subtypes.

Andrew J. Robles, et al. J Med Chem. ;60(22):9275-9289.
6.
Figure 4

Figure 4. From: Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells.

Second generation analogs selectively inhibit growth of LAR cell lines MDA-MB-453 and SUM-185PE. SRB assay concentration-response curves for 24 (A), 26 (B), 27 (C), 28 (D), 30 (E) and 31 (F) in six TNBC cell lines representing five different molecular subtypes. Results represent mean ± SE.

Andrew J. Robles, et al. J Med Chem. ;60(22):9275-9289.
7.
Scheme 2

Scheme 2. Synthesis and structures of analogs 24-34. From: Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells.

Reagent and conditions: (a) NaH (1.1 equiv.), prenylbromide (1 equiv.), ACN (1.0M), 0 °C, 61% yield; (b) p-Toluenesulfonylmethylisocyanide (1.0 equiv.), K2CO3 (1.7 equiv.), MeOH (0.2M), reflux, 98%; (c) 2-bromonicotinaldehyde or 3- bromonicotinaldehyde, Cui (1 equiv.), PPh3 (1 equiv.), Na2CO3 (2 equiv.), DMF (1.0M), 160 °C, 47% yield; (d) HNR, R2 (1.1 equiv.), NaHB(OAc)3, DCE, r.t., 21-71% yield; (e) HC1 (1.0 equiv.), ether (1.0M), r.t.

Andrew J. Robles, et al. J Med Chem. ;60(22):9275-9289.
8.
Scheme 1

Scheme 1. Synthesis of natural products 1 and 2 and analogs 3 and 4. From: Structure-activity relationships of new natural product-based diaryloxazoles with selective activity against androgen receptor-positive breast cancer cells.

Reagent and conditions: (a) p- Toluenesulfonylmethylisocyanide (1.0 equiv.), K2CO3 (1.7 equiv.), MeOH (0.2M), reflux, 97%; (b) Pd(OAc)2 (0.2 equiv.), Cui (1 equiv.), K2C03 (2 equiv.), Ar-Br (1.2 equiv.), DMF (0.85M), mW, 150 °C, 41-55%; (c) Ar-Br (1.2 equiv.), Cui (1 equiv., PPh3 (1 equiv.), Na2CO3 (2 equiv.), DMF (1.0M), 30-65% yield; (d) BBr3 (6 equiv.), DCM (0.2M), −78 °C to r.t., 96% yield; (e) NaH (1.1 equiv.), R-Br (1.1 equiv.), THF/DMF (0.1M), 0 °C to r.t, 28-63%; (f) benzoic acid, HATU, DIPEA, DMF, 57% yield; (g) Cone. H2SO4, AC2O, 90 °C, 85% yield.

Andrew J. Robles, et al. J Med Chem. ;60(22):9275-9289.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center